Skip to main content

Vyndaqel Prices, Coupons and Patient Assistance Programs

Vyndaqel (tafamidis) is a member of the transthyretin stabilizers drug class and is commonly used for Amyloid Cardiomyopathy.

Vyndaqel Prices

The cost for Vyndaqel oral capsule meglumine 20 mg is around $20,622 for a supply of 120 capsules, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

Vyndaqel is available as a brand name drug only, a generic version is not yet available. For more information, read about generic Vyndaqel availability.

This Vyndaqel price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Oral Capsule

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Vyndaqel Coupons and Rebates

Vyndaqel offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Vyndaqel Co-Pay Savings Program: Eligible commercially insured patients may pay as little as $0 per monthly prescription with savings of up to $60,000 per calendar year; for additional information contact the program at 888-222-8475.

Applies to:
Vyndaqel
Number of uses:
per prescription per calendar year
Expires
December 31, 2022

Form more information phone: 888-222-8475 or Visit website

Patient Assistance Programs for Vyndaqel

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: HealthWell Foundation Copay Program

Elligibility requirements:
  1. May have insurance
  2. Varies
  3. FDA Approved Diagnosis - See Program Website for Details
  4. The patient must also be residing in the US.
  5. This program provides financial assistance to eligible individuals to cover coinsurance, copayments, healthcare premiums and deductibles for certain treatments. Also, for those who are eligible for health insurance, but cannot afford the insurance premium, the foundation may be able to help by paying some or all of the medical portion of insurance premiums. The patient is being treated for a specific disease for which funding is available and has insurance that covers the treatment for this disease. Call for most recent medications as the list is subject to change.
Applicable drugs:
  • Vyndaqel (tafamidis meglumine) Capsule

More information please phone: 800-675-8416 Visit Website

Provider: Patient Access Network Foundation (PAN)

Elligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Vyndaqel (tafamidis meglumine) Capsule

More information please phone: 866-316-7263 Visit Website

Provider: VyndaLink Program

Elligibility requirements:
  1. Determined case by case
  2. Not disclosed
  3. FDA-approved diagnosis
  4. The patient must also be residing in the US or Puerto Rico
  5. Co-payment assistance, reimbursement support, and patient assistance programs are available for eligible patients. Education and support services are available; Contact program for details. Please visit: (www.Vyndaqel.com) (www.Vyndamax.com) for more information.
Applicable drugs:
  • Vyndaqel (tafamidis meglumine) Capsule

More information please phone: 888-222-8475 Visit Website

Provider: Pfizer RxPathways

Elligibility requirements:
  1. Contact program for details.
  2. Varies
  3. FDA-approved diagnosis
  4. Must be residing in the US or US territory
  5. Co-payment assistance, and patient assistance programs are available for eligible patients. Call for most recent medications as the list is subject to change.
Applicable drugs:
  • Vyndaqel (tafamidis meglumine) Capsule

More information please phone: 844-989-7284 Visit Website